Ruohola Aino, Heikkinen Terho, Meurman Olli, Puhakka Tuomo, Lindblad Niklas, Ruuskanen Olli
Department of Pediatrics, Turku University Hospital, Turku, Finland.
Pediatrics. 2003 May;111(5 Pt 1):1061-7. doi: 10.1542/peds.111.5.1061.
The role of routine antimicrobial treatment of acute middle-ear infections is under debate, because the efficacy of antimicrobials in the resolution of middle-ear fluid has not been unambiguously proven. Acute tube otorrhea is regarded as evidence of acute otitis media, and for methodologic reasons it was chosen to provide objectivity for diagnostics and outcome assessment. The objective of this study was to assess whether amoxicillin-clavulanate accelerates the resolution of acute tube otorrhea.
Randomized, double-blind, placebo-controlled study in outpatient setting.
Volunteer sample of basically healthy 6- to 72-month-old children with a tympanostomy tube. Eligibility required having acute tube otorrhea of <48 hours' of duration and no prior treatment within the last 2 weeks. The mean age of the participants was 25 months; they had a history of 3 episodes of acute otitis media (median), and 99% had manifestations of a concomitant respiratory infection. Of 79 randomized patients, 7 were withdrawn because of adverse events; 66 patients completed the study.
Amoxicillin-clavulanate (N = 34; 45 mg/kg/d) or matching placebo (N = 32) for 7 days and daily suction of middle-ear fluid through tympanostomy tube.
Duration of acute tube otorrhea and duration of bacterial growth in middle-ear fluid.
The median duration of tube otorrhea was significantly shorter in amoxicillin-clavulanate than in the placebo group (3 vs 8 days). At the end of the 7-day medication period, tube otorrhea was resolved in 28 of 34 children receiving amoxicillin-clavulanate compared with 13 of 32 children on placebo (treatment-control difference 41%; 95% confidence interval, 20%-63%; number needed to treat, 2.4). The median duration of bacterial growth in middle-ear fluid was shorter in amoxicillin-clavulanate than in the placebo group (1 vs 8 days).
Oral antibiotic treatment significantly accelerates the resolution of acute tube otorrhea by reducing bacterial growth in middle-ear fluid.
急性中耳感染的常规抗菌治疗作用存在争议,因为抗菌药物在中耳积液消退方面的疗效尚未得到明确证实。急性鼓膜置管耳漏被视为急性中耳炎的证据,出于方法学原因,选择它为诊断和结果评估提供客观性。本研究的目的是评估阿莫西林 - 克拉维酸是否能加速急性鼓膜置管耳漏的消退。
门诊环境下的随机、双盲、安慰剂对照研究。
6至72个月大、基本健康且有鼓膜置管的儿童志愿者样本。入选条件为急性鼓膜置管耳漏持续时间<48小时且在过去2周内未接受过治疗。参与者的平均年龄为25个月;他们有3次急性中耳炎发作史(中位数),99%有伴随呼吸道感染的表现。79名随机分组的患者中,7名因不良事件退出;66名患者完成了研究。
阿莫西林 - 克拉维酸(N = 34;45毫克/千克/天)或匹配的安慰剂(N = 32),疗程7天,并通过鼓膜置管每日抽吸中耳积液。
急性鼓膜置管耳漏的持续时间和中耳积液中细菌生长的持续时间。
阿莫西林 - 克拉维酸组鼓膜置管耳漏的中位持续时间显著短于安慰剂组(3天对8天)。在7天用药期结束时,34名接受阿莫西林 - 克拉维酸治疗的儿童中有28名鼓膜置管耳漏消退,而安慰剂组32名儿童中有13名消退(治疗 - 对照差异41%;95%置信区间,20% - 63%;需治疗人数,2.4)。阿莫西林 - 克拉维酸组中耳积液中细菌生长的中位持续时间短于安慰剂组(1天对8天)。
口服抗生素治疗通过减少中耳积液中的细菌生长,显著加速急性鼓膜置管耳漏的消退。